Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Discover effective ways to use your points for travel. Maximize your rewards and create unforgettable travel experiences.
22,746 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Synopsys stock stabilizes after a pullback, with analysts signaling meaningful upside driven by AI-enabled chip desig...
Micron’s stock sprinted higher on AI-driven demand, prompting a strategist to flag a potential entry on a pullback. T...
Apple hikes prices on Macs and iPads amid a sharp rise in memory chip costs driven by AI infrastructure demand. The m...
Two former NBA players, Malik Beasley and Ed Davis, were named in a Brooklyn indictment tied to a large betting schem...
Sodexo is accelerating AI and robotics across its kitchen operations to cut labor costs, improve menu execution, and ...
France faces a sharp rise in crypto related abductions, forcing authorities to trace the personal data criminals expl...
Nvidia’s shares lag the broader chip rally even as demand for AI accelerates, prompting questions about earnings timi...
Markets are digesting a potential shift in Fed communication as Kevin Warsh signals a move away from scripted guidanc...
Vodafone Group shares jumped about 13% after a dramatic stake reshuffle that makes Vega the largest shareholder. The ...
NIO delivered a surprising Q4 2025 GAAP profit and outlined a 2026 path to positive non-GAAP earnings, supported by m...
New market analysis shows that a $10,000 investment in JPMorgan when Jamie Dimon took over would be worth six figures...